Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 268 Neoplasm Metastasis 36 Neoplasms 21 Ovarian Neoplasms 17 Advanced Breast Cancer 16 Endometrial Neoplasms 11 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Hereditary Sensory and Autonomic Neuropathies 8 Triple Negative Breast Neoplasms 5 Multiple Endocrine Neoplasia Type 1 5 Breast Diseases 5 Breast Cancer Metastatic 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms by Site 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Recurrence 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Liposarcoma 2 Hyperglycemia 2 HER2-positive Breast Cancer 2

Interventions

pembrolizumab 5 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Watchful Waiting 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡